Synthesis and biological evaluation of propargyl acetate derivatives as anti-mycobacterial agents

BACKGROUND: The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Azerang, Parisa, Rezayan, Ali Hossein, Sardari, Soroush, Kobarfard, Farzad, Bayat, Mitra, Tabib, Kimia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561248/
https://www.ncbi.nlm.nih.gov/pubmed/23351675
http://dx.doi.org/10.1186/2008-2231-20-90
Descripción
Sumario:BACKGROUND: The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular interest. METHODS: This study is focused on propargyl acetate derivatives. Eight molecules were designed based on propargyl alcohols and different acid anhydrides. RESULTS: All the synthesized compounds and commercially available ones were evaluated for anti-tuberculosis activity. CONCLUSIONS: Inhibitors against Mtb have been identified and characterized for further development into potential novel anti-tubercular drugs.

Ejemplares similares